Clinical Trial Update: Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of Triapine to cisplatin-based chemoradiation for cervical and vaginal cancers; results were posted in January 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Vaginal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-01-05